We are currently developing a new impact investment readiness program for social entrepreneurs that meets both their needs and the expectations of impact investors. More information on how it will work will be updated in due time. Thank you for your patience.
The seif Label program was a tailored coaching support program established in collaboration with the Commission for Technology and Innovation aiming at getting social entrepreneurs ready to pitch before investors. The Label was a guarantee for potential investors of the quality of the companies. In 2015 the following enterprises successfully completed the program:
The Swiss biopharmaceutical company BioVersys focuses on research and development of small molecules, which switch off drug resistance against existing antibiotics. With the company’s award-winning TRIC technology it will be possible to restore the efficacy of established antibiotics. BioVersys’ compounds will be used in combination with existing antibiotics, thereby renewing efficacy as well as intellectual property for the established drug. The current research focus is on Nosocomial Infections (hospital infections) and Tuberculosis. In collaboration with GlaxoSmithKline (GSK) and a consortium of the University of Lille, BioVersys aims to develop an effective treatment against Tuberculosis.
The lettuce producers are already present in France, Geneva and Zurich. CombaGroup has developed a unique system with the potential to change the way we produce (and consume) our salads. In an industry where 68% of the salad is wasted they have found a way of locally producing fresh, tasty and beautiful lettuce that utilises 90% less land, 99% less water, 100% less chemicals and can potentially halve emission for each kg of eaten salad.
Since 1993, Velafrica has been collecting disused bicycles in Switzerland and has been exporting them to partners in Sub-Saharan Africa. With more than 140’000 bicycles shipped to Ghana, Eritrea, Gambia, Burkina Faso, Tanzania or Madagascar, Velafrica has a remarkable track-record and is today with 15’000 bicycles per year one of the leading agencies for recycled bicycles worldwide.
One third of all people who contact the general practitioner have no medically diagnosable complaint. Most of these people are therefore seeking for an alternative solution in the secondary healthcare market. But the very fragmented and non-transparent structure of the market makes it difficult for patients to find qualified support, and nobody helps them to take the right choice.
Prof. Mariana Christen Jakob
CEO & Founder, Chair of the Jury
Co-Founder & CEO
Founder & Director
Prof. Dr.-Ing. Lutz-P. Nolte
Head of Impact Research
Dr. Magne Y. Orgland
Dr. iur. Karim Maizar
Attorney at Law